PAVmed Inc.
PAVM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,069 | $29,794 | $42,757 | $190,689 |
| - Cash | $1,185 | $19,639 | $39,744 | $77,258 |
| + Debt | $31,860 | $48,725 | $36,637 | $0 |
| Enterprise Value | $36,744 | $58,880 | $39,650 | $113,431 |
| Revenue | $2,995 | $2,452 | $377 | $500 |
| % Growth | 22.1% | 550.4% | -24.6% | – |
| Gross Profit | -$3,043 | -$3,968 | -$3,237 | -$85 |
| % Margin | -101.6% | -161.8% | -858.6% | -17% |
| EBITDA | $29,670 | -$75,742 | -$99,500 | -$55,900 |
| % Margin | 990.7% | -3,089% | -26,392.6% | -11,180% |
| Net Income | $39,791 | -$64,175 | -$88,983 | -$50,347 |
| % Margin | 1,328.6% | -2,617.3% | -23,602.9% | -10,069.4% |
| EPS Diluted | 0.496 | -9.164 | -15.032 | -9.797 |
| % Growth | 105.4% | 39% | -53.4% | – |
| Operating Cash Flow | -$33,554 | -$52,036 | -$70,985 | -$40,591 |
| Capital Expenditures | -$55 | -$242 | -$1,540 | -$1,469 |
| Free Cash Flow | -$33,609 | -$52,278 | -$72,525 | -$42,060 |